Knapp J, Bernhard M, Haltmeier T, Bieler D, Hossfeld B, Kulla M
Universitätsklinik für Anästhesiologie und Schmerztherapie, Universitätsspital Bern, Freiburgstrasse 8, Bern, Schweiz.
Zentrale Notaufnahme, Universitätsklinikum Leipzig, Leipzig, Deutschland.
Anaesthesist. 2018 Apr;67(4):280-292. doi: 10.1007/s00101-018-0418-5.
Hemorrhage is the single largest cause of avoidable death in trauma patients, whereby in civil emergency medicine in Europe most life-threatening hemorrhages occur in the abdomen and the pelvis. This is one reason why endovascular balloon occlusion of the aorta (EBOA), a procedure especially established in vascular surgery, is increasingly propagated for rapid bleeding control in these patients. This review article provides a comprehensive overview of the technique, indications, contraindications and complications of resuscitative endovascular balloon occlusion of the aorta (REBOA). Additionally, outcomes reported in in the currently available literature are summarized and discussed. From this practical and user-oriented consequences for future successful introduction of REBOA in the field of emergency medicine are deduced.
出血是创伤患者可避免死亡的单一最大原因，在欧洲的民事急诊医学中，大多数危及生命的出血发生在腹部和骨盆。这就是为什么血管外科专门设立的一种手术——主动脉内球囊阻断术（EBOA），越来越多地被推广用于这些患者的快速出血控制。这篇综述文章全面概述了复苏性主动脉内球囊阻断术（REBOA）的技术、适应症、禁忌症和并发症。此外，还总结和讨论了现有文献中报道的结果。由此推断出在急诊医学领域成功引入REBOA的未来实际且以用户为导向的结果。
